Increasing Costs for Cancer Drugs: Hospitals Grapple with Nationwide Shortage


As the landscape of medicine evolves, hospitals and cancer clinics grapple with a widespread scarcity of cancer drugs. This situation has been affecting cancer patients since the initial announcement in June. This impact is evident even in the Coastal Bend region. Oncologists are now facing a situation where prices of essential life-saving drugs have surged, with pharmaceutical companies increasing their prices by nearly tenfold.

Amid over a dozen cancer drug scarcity, physicians must explore alternative approaches to care for their patients. The escalated prices have impacted at least one out of every three hospitals. Notably, the commonly used cancer medication, Carboplatin, typically costs $29, has now skyrocketed to over $300.

The drug shortage has had a significant impact on Driscoll Children’s Hospital. However, Dr. Farha Sherani, a pediatric oncology physician, explains that they are employing creative strategies to maximize the use of available medications.

“For instance, the 2ML vials of Methotrexate are no longer accessible. Consequently, we are utilizing the 40ML vials of Methotrexate in stock. Regrettably, a substantial portion goes to waste as only a limited number of patients require the drug on any given day,” Sherani explained.

Medical experts attribute the situation to gray market vendors allegedly purchasing and reselling the necessary medications at exorbitant prices. Dr. Sherani mentioned that when several of her patients require treatments within a week of each other, she coordinates their appointments to coincide, aiming to preserve the available medications.

“Many of these cancer drugs lack viable alternatives,” Sherani emphasized. “It’s not akin to choosing between a banana and an apple. You can’t simply decide, ‘Today, I’ll opt for an apple instead of a banana.’ The comparison doesn’t hold – our options for substituting drugs are severely limited.”

The pressing question on many minds revolves around the solution to this predicament. According to Dr. Sherani, the solution is a complex one. She envisions that resolving this issue will necessitate a multifaceted approach involving political interventions, changes within the pharmaceutical industry, and adjustments made by healthcare companies.

The reality remains that certain hospitals or clinics might need to shoulder the additional medication expenses. Nevertheless, the overarching aspiration is to prevent patients from enduring undue hardships during this interim period.

Close No menu locations found.